intermediate-high-risk acute pulmonary embolism
Conditions
Brief summary
The primary outcome is the composite of (1) death from any cause, or (2) hemodynamic decompensation, or (3) objectively confirmed recurrent PE at day 30.
Detailed description
Fatal or GUSTO severe or life-threatening bleeding within 30 days, Net clinical benefit defined as the composite of the primary efficacy outcome and GUSTO severe or life-threatening bleeding within 30 days, All-cause mortality within 30 days
Interventions
Sponsors
Assistance Publique Hopitaux De Paris
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the composite of (1) death from any cause, or (2) hemodynamic decompensation, or (3) objectively confirmed recurrent PE at day 30. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatal or GUSTO severe or life-threatening bleeding within 30 days, Net clinical benefit defined as the composite of the primary efficacy outcome and GUSTO severe or life-threatening bleeding within 30 days, All-cause mortality within 30 days | — |
Countries
Austria, France, Germany, Italy, Netherlands, Poland, Slovenia, Spain
Outcome results
None listed